This document presents an accepted set of principles for the safety evaluation of drugs intended for the long-term treatment (chronic or repeated intermittent use for longer than 6 months) of non-life-threatening diseases.

Keywords: Safety evaluation, long-term treatment, short term exposure, non-life threatening diseases, adverse drug events (ADEs), adverse event rate, background event rate, causality

Current effective version

How useful do you find this page?